![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Ahmed Kaseb, ESMO 2019 - Nivolumab plus ipilimumab in HCC (Touch Medical Media) View |
![]() |
ESMO 2017 highlights on managing difficult to treat cancers (ecancer) View |
![]() |
Hepatocellular Carcinoma Debate - Logoregional treatment first (HMP Education) View |
![]() |
How to Integrate New Agents in HCC: The Role of Checkpoint Inhibitors (HMP Education) View |
![]() |
Multidisciplinary Tumor Board on HCC (HMP Education) View |
![]() |
New targets and new agents in HCC (HMP Education) View |
![]() |
Interactive session on hepatocellular cancer guidelines - Clinical case discussion (HMP Education) View |
![]() |
Tandem Talk 3: Hepatocellular carcinoma - Locoregional Treatment (HMP Education) View |
![]() |
How to Integrate New Agents in HCC: The Role of TKIs (HMP Education) View |
![]() |
GI Cancer ESMO 2024 Highlights: Key Studies Discussed LEAP-012, KEYNOTE-811, POD1UM-303, NICHE-2 (OncBrothers: Practice-Changing Cancer Discussions) View |